News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Satvat Ali J.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2021 |
4
| Satvat Ali J. (Director) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Granted 38,895 options to buy
@ $62.63, valued at
$2.4M
|
|
| 04/22/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 01/28/2021 |
4
| Satvat Ali J. (Director) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Granted 39,851 options to buy
@ $26.21, valued at
$1M
Granted 39,851 options to buy
@ $16.68, valued at
$664.7k
Granted 79,702 options to buy
@ $10.99, valued at
$875.9k
|
|
| 01/28/2021 |
4
| Satvat Ali J. (Director) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Disposed/sold 21,528 options to buy
@ $48.51, valued at
$1M
Disposed/sold 21,528 options to buy
@ $30.87, valued at
$664.6k
Disposed/sold 43,056 options to buy
@ $20.34, valued at
$875.8k
|
|
| 06/04/2020 |
4
| Satvat Ali J. (10% Owner) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Granted 112,422 options to buy
@ $29, valued at
$3.3M
|
|
| 05/29/2020 |
4
| Satvat Ali J. (10% Owner) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Granted 21,528 options to buy
@ $48.51, valued at
$1M
|
|
| 01/14/2020 |
4
| Satvat Ali J. (Director) has filed a Form 4 on Coherus BioSciences, Inc.|
Txns:
| Granted 20,000 options to buy
@ $17.73, valued at
$354.6k
|
|
| 12/16/2019 |
4
| Satvat Ali J. (10% Owner) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Granted 82,878 options to buy
@ $37.45, valued at
$3.1M
|
|
| 07/08/2019 |
4
| Satvat Ali J. (10% Owner) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Bought 882,353 shares
@ $29.9005, valued at
$26.4M
|
|
| 06/27/2019 |
3
| Satvat Ali J. (Director) has filed a Form 3 on BridgeBio Pharma, Inc. |
| 06/13/2019 |
4
| Satvat Ali J. (10% Owner) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Granted 21,528 options to buy
@ $30.87, valued at
$664.6k
|
|
| 05/29/2019 |
4
| Satvat Ali J. (10% Owner) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Bought 1,103,848 shares
@ $25.93, valued at
$28.6M
|
|
| 02/14/2019 |
5
| Satvat Ali J. (10% Owner) has filed a Form 5 on Eidos Therapeutics, Inc. |
| 01/30/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/03/2018 |
4
| Satvat Ali J. (10% Owner) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Granted 43,056 options to buy
@ $20.34, valued at
$875.8k
|
|
| 06/22/2018 |
4
| Satvat Ali J. (10% Owner) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Converted 18,826,417 shares
@ $0
Paid exercise price by delivering 211,762 shares
@ $17, valued at
$3.6M
Bought 1,000,000 shares
@ $17, valued at
$17M
Exercised (in-or-at-the-money) 332,262 warrants
@ $10.8348, valued at
$3.6M
Exercised (in-or-at-the-money) 332,262 convertible preferred
@ $0
Converted 2,909,029 convertible preferred
@ $0
Converted 12,832,123 options to buy
@ $0 |
|
| 06/19/2018 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/05/2018 |
4
| Satvat Ali J. (Director) has filed a Form 4 on Coherus BioSciences, Inc.|
Txns:
| Granted 20,000 options to buy
@ $10.05, valued at
$201k
|
|
| 05/19/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/26/2016 |
4
| Satvat Ali J. (Director) has filed a Form 4 on Coherus BioSciences, Inc.|
Txns:
| Granted 10,000 options to buy
@ $18.28, valued at
$182.8k
|
|
|
|